The Lancet Public Health

The Lancet Public Health
Title	The Lancet Public Health
Discipline	Public health
Abbreviation	Lancet Public Health
Publisher	Elsevier
Country	United Kingdom
History	2016–present
Frequency	Monthly
Openaccess	Hybrid

The Lancet Public Health is a monthly peer-reviewed medical journal publishing research, commentary, and analysis on population health, preventive interventions, and health systems. Established to extend the The Lancet family into population-level issues, the journal engages with policymakers, clinicians, and researchers across disciplines including World Health Organization, United Nations, Centers for Disease Control and Prevention, European Commission, and national health agencies. Editorial leadership has included figures connected with institutions such as Harvard University, University of Oxford, London School of Hygiene & Tropical Medicine, Johns Hopkins University, and Imperial College London.

History

The journal was launched in 2016 by Elsevier as a sibling to The Lancet and The Lancet Oncology, following trends set by titles such as The Lancet Infectious Diseases and The Lancet Neurology. Early issues featured collaborations with organizations including World Health Organization, Bill & Melinda Gates Foundation, Wellcome Trust, Robert Wood Johnson Foundation, and National Institutes of Health. Editorial boards have drawn on scholars from University College London, King's College London, University of Cambridge, Columbia University, and Yale University and have reflected priorities of global initiatives such as the Sustainable Development Goals and the Global Burden of Disease Study. The launch paralleled the expansion of specialty journals like The Lancet Planetary Health and responded to policy debates involving Affordable Care Act, National Health Service, and European Centre for Disease Prevention and Control.

Scope and Editorial Focus

The journal focuses on epidemiology, health policy, social determinants, and preventive strategies, publishing work relevant to institutions such as World Health Organization, Pan American Health Organization, Médecins Sans Frontières, Gavi, the Vaccine Alliance, and UNICEF. Editorial priorities emphasize metrics and methods associated with the Global Burden of Disease Study, randomized trials connected to Framingham Heart Study methodologies, and modelling approaches used by groups at Imperial College London and Institute for Health Metrics and Evaluation. Content often intersects with topics linked to Human Rights Council, European Medicines Agency, Food and Agriculture Organization, International Labour Organization, and high-profile events such as COP26 and World Health Assembly.

Publication and Access Model

Published by Elsevier under the Lancet imprint alongside titles referencing The Lancet, the journal operates a hybrid open access model consistent with funder mandates from entities like the Wellcome Trust, Bill & Melinda Gates Foundation, and UK Research and Innovation. Submission and peer review processes align with standards promoted by organizations including the Committee on Publication Ethics, International Committee of Medical Journal Editors, and indexing expectations of PubMed Central. The journal’s editorial correspondence and commentaries have been cited in reports by European Commission, United Nations Development Programme, and national bodies such as Public Health England and the Centers for Disease Control and Prevention.

Abstracting and Indexing

The journal is indexed in major databases and platforms such as PubMed, MEDLINE, Science Citation Index Expanded, Scopus, and Embase, meeting criteria comparable to other titles like BMJ and JAMA. Bibliometric data are tracked by organizations including Clarivate Analytics and Elsevier’s internal metrics, and citation analyses often reference frameworks used by H-index compilers, Institute for Scientific Information, and the Global Health Observatory. Libraries and consortia such as Europe PubMed Central and the National Library of Medicine include the journal in their collections.

Reception and Impact

The journal has been recognized for shaping debates that involve stakeholders such as World Health Organization, United Nations, G20, European Union, and national ministries of health including those of United Kingdom, United States, India, Brazil, and China. High-profile commentaries have been debated in venues like World Economic Forum sessions and cited in policy briefs from OECD and the International Monetary Fund when public-health evidence intersected with economic forecasts. The title’s impact factor and altmetric attention have been compared with peer journals such as The Lancet, The Lancet Global Health, BMJ Global Health, and PLOS Medicine.

Notable Articles and Series

Notable pieces have addressed topics tied to the Global Burden of Disease Study, pandemic preparedness linked to the 2019–20 coronavirus pandemic, vaccination programmes evaluated in collaboration with Gavi, the Vaccine Alliance and WHO, and air-pollution analyses referencing data from the European Environment Agency and United States Environmental Protection Agency. Series and commissions have engaged experts from Harvard T.H. Chan School of Public Health, Johns Hopkins Bloomberg School of Public Health, London School of Hygiene & Tropical Medicine, University of Toronto, and McMaster University, and have influenced reports by World Health Organization, United Nations Environment Programme, and World Bank initiatives.

Category:Medical journals Category:Public health